LAMBERTI, GIUSEPPE
LAMBERTI, GIUSEPPE
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs
2025 Polici, M.; Caruso, D.; Masci, B.; Marasco, M.; Valanzuolo, D.; Dell'Unto, E.; Zerunian, M.; Campana, D.; De Santis, D.; Lamberti, G.; Iannicelli, E.; Prosperi, D.; Annibale, B.; Laghi, A.; Panzuto, F.; Rinzivillo, M.
Reply to ‘The need for a better classification system for gastric neoplasms’
2025 Lamberti, G.; Campana, D.
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors
2024 Pecci F.; Nakazawa S.; Ricciuti B.; Harada G.; Lee J.K.; Alessi J.V.; Barrichello A.; Vaz V.R.; Lamberti G.; Di Federico A.; Gandhi M.M.; Gazgalis D.; Feng W.W.; Jiang J.; Baldacci S.; Locquet M.-A.; Gottlieb F.H.; Chen M.F.; Lee E.; Haradon D.; Smokovich A.; Voligny E.; Nguyen T.; Goel V.K.; Zimmerman Z.; Atwal S.; Wang X.; Bahcall M.; Heist R.S.; Iqbal S.; Gandhi N.; Elliott A.; Vanderwalde A.M.; Ma P.C.; Halmos B.; Liu S.V.; Che J.; Schrock A.B.; Drilon A.; Janne P.A.; Awad M.M.
Challenges and future perspectives for the use of temozolomide in the treatment of SCLC
2024 Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de Biase D.; Campana D.; Lamberti G.
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
2024 Panzuto, F.; Partelli, S.; Campana, D.; De Braud, F.; Spada, F.; Cives, M.; Tafuto, S.; Bertuzzi, A.; Gelsomino, F.; Bergamo, F.; Marcucci, S.; Mastrangelo, L.; Massironi, S.; Appetecchia, M.; Filice, A.; Badalamenti, G.; Bartolomei, M.; Amoroso, V.; Landoni, L.; Rodriquenz, M. G.; Valente, M.; Colao, A.; Isidori, A.; Fanciulli, G.; Bollina, R.; Ciola, M.; Butturini, G.; Marconcini, R.; Arvat, E.; Cinieri, S.; Berardi, R.; Baldari, S.; Riccardi, F.; Spoto, C.; Giuffrida, D.; Gattuso, D.; Ferone, D.; Rinzivillo, M.; Bertani, E.; Versari, A.; Zerbi, A.; Lamberti, G.; Lauricella, E.; Pusceddu, S.; Fazio, N.; Dell'Unto, E.; Marini, M.; Falconi, M.
Gastric neuroendocrine neoplasms
2024 Lamberti, Giuseppe; Panzuto, Francesco; Pavel, Marianne; O'Toole, Dermot; Ambrosini, Valentina; Falconi, Massimo; Garcia-Carbonero, Rocio; Riechelmann, Rachel P.; Rindi, Guido; Campana, Davide
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer
2024 Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M.
Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer
2024 Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; Lamberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M.
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients
2024 Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, Elena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
2024 Fletcher K.; Cortellini A.; Ganta T.; Kankaria R.; Song H.; Ye F.; Irlmeier R.; Debnath N.; Saeed A.; Radford M.; Alahmadi A.; Diamond A.; Hoimes C.; Presley C.J.; Owen D.H.; Abou Alaiwi S.; Nassar A.H.; Lamberti G.; Perrone F.; Buti S.; Giusti R.; Filetti M.; Vanella V.; Mallardo D.; Sussman T.A.; Galetta D.; Kalofonou F.; Daniels E.; Ascierto P.A.; Pinato D.J.; Nebhan C.; Berg S.; Choueiri T.K.; Marron T.U.; Wang Y.; Naqash A.R.; Johnson D.B.
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
2024 Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongiovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D.
Tackling hurdles in front of young clinical investigators in oncology – Results from an international survey
2024 Vasileva-Slaveva M.; Morales-Espinosa D.; Puccini A.; Meissner M.; Milic M.; Lamberti G.; Altena R.
Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
2024 Wang X.; Lamberti G.; Di Federico A.; Alessi J.; Ferrara R.; Sholl M.L.; Awad M.M.; Vokes N.; Ricciuti B.
β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients
2024 Di Franco M.; Fortunati E.; Zanoni L.; Bonazzi N.; Mosconi C.; Malizia C.; Civollani S.; Campana D.; Andrini E.; Lamberti G.; Allegri V.; Fanti S.; Ambrosini V.
An Update on Appendiceal Neuroendocrine Tumors
2023 Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D.
Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis
2023 Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Valentina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo
BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature
2023 Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; Lamberti G.
Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review
2023 Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Maria Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
2023 Thummalapalli R.; Ricciuti B.; Bandlamudi C.; Muldoon D.; Rizvi H.; Elkrief A.; Luo J.; Alessi J.V.; Pecci F.; Lamberti G.; Di Federico A.; Hong L.; Zhang J.; Heymach J.V.; Gibbons D.L.; Plodkowski A.J.; Ravichandran V.; Donoghue M.T.A.; Vanderbilt C.; Ladanyi M.; Rudin C.M.; Kris M.G.; Riely G.J.; Chaft J.E.; Hellmann M.D.; Vokes N.I.; Awad M.M.; Schoenfeld A.J.
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
2023 Alessi J.V.; Elkrief A.; Ricciuti B.; Wang X.; Cortellini A.; Vaz V.R.; Lamberti G.; Frias R.L.; Venkatraman D.; Fulgenzi C.A.M.; Pecci F.; Recondo G.; Di Federico A.; Barrichello A.; Park H.; Nishino M.; Hambelton G.M.; Egger J.V.; Ladanyi M.; Digumarthy S.; Johnson B.E.; Christiani D.C.; Lin X.; Gainor J.F.; Lin J.J.; Pinato D.J.; Schoenfeld A.J.; Awad M.M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Radiomics in advanced gastroenteropancreatic neuroendocrine neoplasms: Identifying responders to somatostatin analogs | Polici, M.; Caruso, D.; Masci, B.; Marasco, M.; Valanzuolo, D.; Dell'Unto, E.; Zerunian, M.; Camp...ana, D.; De Santis, D.; Lamberti, G.; Iannicelli, E.; Prosperi, D.; Annibale, B.; Laghi, A.; Panzuto, F.; Rinzivillo, M. | 2025-01-01 | JOURNAL OF NEUROENDOCRINOLOGY | - | 1.01 Articolo in rivista | JNE-37-e13472.pdf |
| Reply to ‘The need for a better classification system for gastric neoplasms’ | Lamberti, G.; Campana, D. | 2025-01-01 | NATURE REVIEWS. DISEASE PRIMERS | - | 1.04 Replica / breve intervento (e simili) | - |
| Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors | Pecci F.; Nakazawa S.; Ricciuti B.; Harada G.; Lee J.K.; Alessi J.V.; Barrichello A.; Vaz V.R.; L...amberti G.; Di Federico A.; Gandhi M.M.; Gazgalis D.; Feng W.W.; Jiang J.; Baldacci S.; Locquet M.-A.; Gottlieb F.H.; Chen M.F.; Lee E.; Haradon D.; Smokovich A.; Voligny E.; Nguyen T.; Goel V.K.; Zimmerman Z.; Atwal S.; Wang X.; Bahcall M.; Heist R.S.; Iqbal S.; Gandhi N.; Elliott A.; Vanderwalde A.M.; Ma P.C.; Halmos B.; Liu S.V.; Che J.; Schrock A.B.; Drilon A.; Janne P.A.; Awad M.M. | 2024-01-01 | CANCER DISCOVERY | - | 1.01 Articolo in rivista | cd-23-1217.pdf; 7384706.zip |
| Challenges and future perspectives for the use of temozolomide in the treatment of SCLC | Andrini E.; Ricco G.; Zappi A.; Aloi S.; Giordano M.; Altimari A.; Gruppioni E.; Maloberti T.; de... Biase D.; Campana D.; Lamberti G. | 2024-01-01 | CANCER TREATMENT REVIEWS | - | 1.01 Articolo in rivista | - |
| Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database | Panzuto, F.; Partelli, S.; Campana, D.; De Braud, F.; Spada, F.; Cives, M.; Tafuto, S.; Bertuzzi,... A.; Gelsomino, F.; Bergamo, F.; Marcucci, S.; Mastrangelo, L.; Massironi, S.; Appetecchia, M.; Filice, A.; Badalamenti, G.; Bartolomei, M.; Amoroso, V.; Landoni, L.; Rodriquenz, M. G.; Valente, M.; Colao, A.; Isidori, A.; Fanciulli, G.; Bollina, R.; Ciola, M.; Butturini, G.; Marconcini, R.; Arvat, E.; Cinieri, S.; Berardi, R.; Baldari, S.; Riccardi, F.; Spoto, C.; Giuffrida, D.; Gattuso, D.; Ferone, D.; Rinzivillo, M.; Bertani, E.; Versari, A.; Zerbi, A.; Lamberti, G.; Lauricella, E.; Pusceddu, S.; Fazio, N.; Dell'Unto, E.; Marini, M.; Falconi, M. | 2024-01-01 | ENDOCRINE | - | 1.01 Articolo in rivista | Endocrine_Panzuto_Itanet.pdf; 12020_2023_3649_MOESM1_ESM.docx |
| Gastric neuroendocrine neoplasms | Lamberti, Giuseppe; Panzuto, Francesco; Pavel, Marianne; O'Toole, Dermot; Ambrosini, Valentina; F...alconi, Massimo; Garcia-Carbonero, Rocio; Riechelmann, Rachel P.; Rindi, Guido; Campana, Davide | 2024-01-01 | NATURE REVIEWS. DISEASE PRIMERS | - | 1.01 Articolo in rivista | - |
| Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer | Ricciuti B.; Lamberti G.; Puchala S.R.; Mahadevan N.R.; Lin J.-R.; Alessi J.V.; Chowdhury A.; Li ...Y.Y.; Wang X.; Spurr L.; Pecci F.; Di Federico A.; Venkatraman D.; Barrichello A.P.; Gandhi M.; Vaz V.R.; Pangilinan A.J.; Haradon D.; Lee E.; Gupta H.; Pfaff K.L.; Welsh E.L.; Nishino M.; Cherniack A.D.; Johnson B.E.; Weirather J.L.; Dryg I.D.; Rodig S.J.; Sholl L.M.; Sorger P.; Santagata S.; Umeton R.; Awad M.M. | 2024-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | jco-42-1311.pdf |
| Intrapatient variation in PD-L1 expression and tumor mutational burden and the impact on outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer | Di Federico, A.; Alden, S. L.; Smithy, J. W.; Ricciuti, B.; Alessi, J. V.; Wang, X.; Pecci, F.; L...amberti, G.; Gandhi, M. M.; Vaz, V. R.; Spurr, L. F.; Sholl, L. M.; Pfaff, K. L.; Rodig, S. J.; Li, Y. Y.; Cherniack, A. D.; Nishino, M.; Johnson, B. E.; Awad, M. M. | 2024-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients | Bonazzi, Norma; Fortunati, Emilia; Zanoni, Lucia; Argalia, Giulia; Calabrò, Diletta; Tabacchi, El...ena; Allegri, Vincenzo; Campana, Davide; Andrini, Elisa; Lamberti, Giuseppe; Di Franco, Martina; Casadei, Riccardo; Ricci, Claudio; Mosconi, Cristina; Fanti, Stefano; Ambrosini, Valentina | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-00701.pdf |
| Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study | Fletcher K.; Cortellini A.; Ganta T.; Kankaria R.; Song H.; Ye F.; Irlmeier R.; Debnath N.; Saeed... A.; Radford M.; Alahmadi A.; Diamond A.; Hoimes C.; Presley C.J.; Owen D.H.; Abou Alaiwi S.; Nassar A.H.; Lamberti G.; Perrone F.; Buti S.; Giusti R.; Filetti M.; Vanella V.; Mallardo D.; Sussman T.A.; Galetta D.; Kalofonou F.; Daniels E.; Ascierto P.A.; Pinato D.J.; Nebhan C.; Berg S.; Choueiri T.K.; Marron T.U.; Wang Y.; Naqash A.R.; Johnson D.B. | 2024-01-01 | CANCER LETTERS | - | 1.01 Articolo in rivista | Fletcher_2024.pdf |
| Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort | Panzuto F.; Andrini E.; Lamberti G.; Pusceddu S.; Rinzivillo M.; Gelsomino F.; Raimondi A.; Bongi...ovanni A.; Davi M.V.; Cives M.; Brizzi M.P.; Persano I.; Zatelli M.C.; Puliafito I.; Tafuto S.; Campana D. | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-13-02074.pdf |
| Tackling hurdles in front of young clinical investigators in oncology – Results from an international survey | Vasileva-Slaveva M.; Morales-Espinosa D.; Puccini A.; Meissner M.; Milic M.; Lamberti G.; Altena R. | 2024-01-01 | EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities | Wang X.; Lamberti G.; Di Federico A.; Alessi J.; Ferrara R.; Sholl M.L.; Awad M.M.; Vokes N.; Ric...ciuti B. | 2024-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| β1600 Q.Clear Digital Reconstruction of [68Ga]Ga-DOTANOC PET/CT Improves Image Quality in NET Patients | Di Franco M.; Fortunati E.; Zanoni L.; Bonazzi N.; Mosconi C.; Malizia C.; Civollani S.; Campana ...D.; Andrini E.; Lamberti G.; Allegri V.; Fanti S.; Ambrosini V. | 2024-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-13-03841-v2.pdf |
| An Update on Appendiceal Neuroendocrine Tumors | Andrini E.; Lamberti G.; Alberici L.; Ricci C.; Campana D. | 2023-01-01 | CURRENT TREATMENT OPTIONS IN ONCOLOGY | - | 1.01 Articolo in rivista | Andrini_2023.pdf |
| Appendiceal goblet cell carcinoma has marginal advantages from perioperative chemotherapy: a population-based study with an entropy balancing analysis | Ricci, Claudio; Campana, Davide; Ingaldi, Carlo; Lamberti, Giuseppe; Alberici, Laura; Tateo, Vale...ntina; Castagna, Giovanni; Ricco, Gianluca; Calderaro, Fulvio; Malvi, Deborah; Rosini, Francesca; Casadei, Riccardo | 2023-01-01 | LANGENBECK'S ARCHIVES OF SURGERY | - | 1.01 Articolo in rivista | GCC_cht_SEER.pdf |
| BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: A case report and review of the literature | Ricco G.; Seminerio R.; Andrini E.; Malvi D.; Gruppioni E.; Altimari A.; Zagnoni S.; Campana D.; ...Lamberti G. | 2023-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Chemotherapy in Well Differentiated Neuroendocrine Tumors (NET) G1, G2, and G3: A Narrative Review | Arianna Zappi; irene persano; Linda Galvani; Elena Parlagreco; Elisa Andrini; Davide Campana; Mar...ia Pia Brizzi; Giuseppe Lamberti; ANNA LA SALVIA | 2023-01-01 | JOURNAL OF CLINICAL MEDICINE | - | 1.01 Articolo in rivista | jcm-12-00717.pdf |
| Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer | Thummalapalli R.; Ricciuti B.; Bandlamudi C.; Muldoon D.; Rizvi H.; Elkrief A.; Luo J.; Alessi J....V.; Pecci F.; Lamberti G.; Di Federico A.; Hong L.; Zhang J.; Heymach J.V.; Gibbons D.L.; Plodkowski A.J.; Ravichandran V.; Donoghue M.T.A.; Vanderbilt C.; Ladanyi M.; Rudin C.M.; Kris M.G.; Riely G.J.; Chaft J.E.; Hellmann M.D.; Vokes N.I.; Awad M.M.; Schoenfeld A.J. | 2023-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | Thummalapalli_2021.pdf; 6908245.zip |
| Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC | Alessi J.V.; Elkrief A.; Ricciuti B.; Wang X.; Cortellini A.; Vaz V.R.; Lamberti G.; Frias R.L.; ...Venkatraman D.; Fulgenzi C.A.M.; Pecci F.; Recondo G.; Di Federico A.; Barrichello A.; Park H.; Nishino M.; Hambelton G.M.; Egger J.V.; Ladanyi M.; Digumarthy S.; Johnson B.E.; Christiani D.C.; Lin X.; Gainor J.F.; Lin J.J.; Pinato D.J.; Schoenfeld A.J.; Awad M.M. | 2023-01-01 | JOURNAL OF THORACIC ONCOLOGY | - | 1.01 Articolo in rivista | - |